US FDA Approves Roche’s COVID-19 Antibody Treatment
Roche reported that the U.S. Food and Drug Organization (FDA) has supported Actemra intravenous for the treatment of Coronavirus in hospitalized grown-up patients who are getting foundational corticosteroids and require supplemental oxygen, painless or obtrusive mechanical ventilation, or extracorporeal film oxygenation (ECMO). Actemra is the first monoclonal antibody for COVID-19 treatment that has been approved […]
Continue Reading